A detailed history of Russell Investments Group, Ltd. transactions in Bio Techne Corp stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 137,650 shares of TECH stock, worth $9.83 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
137,650
Previous 147,976 6.98%
Holding current value
$9.83 Million
Previous $10.6 Million 3.74%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$70.96 - $82.35 $732,732 - $850,346
-10,326 Reduced 6.98%
137,650 $11 Million
Q2 2024

Aug 08, 2024

BUY
$62.12 - $84.15 $993,920 - $1.35 Million
16,000 Added 12.12%
147,976 $10.6 Million
Q1 2024

May 08, 2024

SELL
$65.98 - $77.09 $5.29 Million - $6.19 Million
-80,251 Reduced 37.81%
131,976 $9.29 Million
Q4 2023

Feb 05, 2024

BUY
$52.83 - $78.22 $4.41 Million - $6.54 Million
83,569 Added 64.95%
212,227 $16.4 Million
Q3 2023

Nov 13, 2023

BUY
$67.52 - $89.42 $298,033 - $394,699
4,414 Added 3.55%
128,658 $8.76 Million
Q2 2023

Aug 10, 2023

BUY
$73.76 - $85.98 $552,093 - $643,560
7,485 Added 6.41%
124,244 $10.1 Million
Q1 2023

May 09, 2023

SELL
$71.62 - $86.62 $206,552 - $249,812
-2,884 Reduced 2.41%
116,759 $8.66 Million
Q4 2022

Feb 08, 2023

BUY
$80.67 - $352.29 $6.96 Million - $30.4 Million
86,268 Added 258.48%
119,643 $9.92 Million
Q3 2022

Nov 04, 2022

SELL
$282.54 - $391.85 $829,537 - $1.15 Million
-2,936 Reduced 8.09%
33,375 $9.48 Million
Q2 2022

Jul 29, 2022

SELL
$322.67 - $449.65 $345,256 - $481,125
-1,070 Reduced 2.86%
36,311 $12.6 Million
Q1 2022

May 05, 2022

SELL
$353.85 - $487.79 $1.85 Million - $2.55 Million
-5,220 Reduced 12.25%
37,381 $16.2 Million
Q4 2021

Jan 21, 2022

BUY
$456.15 - $525.06 $760,858 - $875,800
1,668 Added 4.07%
42,601 $22 Million
Q3 2021

Nov 08, 2021

BUY
$444.87 - $538.88 $857,709 - $1.04 Million
1,928 Added 4.94%
40,933 $19.9 Million
Q2 2021

Aug 04, 2021

BUY
$387.35 - $450.26 $2.65 Million - $3.08 Million
6,849 Added 21.3%
39,005 $17.6 Million
Q1 2021

May 10, 2021

SELL
$314.62 - $411.0 $2.28 Million - $2.98 Million
-7,240 Reduced 18.38%
32,156 $12.3 Million
Q4 2020

Feb 08, 2021

SELL
$246.9 - $321.87 $2.09 Million - $2.72 Million
-8,452 Reduced 17.66%
39,396 $12.5 Million
Q3 2020

Nov 09, 2020

BUY
$232.22 - $282.96 $1.76 Million - $2.14 Million
7,576 Added 18.81%
47,848 $11.9 Million
Q2 2020

Aug 05, 2020

BUY
$185.43 - $279.56 $685,534 - $1.03 Million
3,697 Added 10.11%
40,272 $10.6 Million
Q1 2020

May 06, 2020

SELL
$161.17 - $221.51 $171,646 - $235,908
-1,065 Reduced 2.83%
36,575 $6.93 Million
Q4 2019

Jan 29, 2020

BUY
$189.68 - $222.09 $693,659 - $812,183
3,657 Added 10.76%
37,640 $8.26 Million
Q3 2019

Nov 01, 2019

SELL
$183.56 - $216.72 $149,417 - $176,410
-814 Reduced 2.34%
33,983 $6.65 Million
Q2 2019

Aug 09, 2019

SELL
$188.72 - $215.43 $353,850 - $403,931
-1,875 Reduced 5.11%
34,797 $7.26 Million
Q1 2019

May 13, 2019

SELL
$136.09 - $200.44 $120,984 - $178,191
-889 Reduced 2.37%
36,672 $7.28 Million
Q4 2018

Feb 11, 2019

SELL
$132.75 - $203.8 $3.46 Million - $5.31 Million
-26,064 Reduced 40.97%
37,561 $5.44 Million
Q3 2018

Oct 26, 2018

SELL
$147.44 - $204.11 $4.02 Million - $5.56 Million
-27,246 Reduced 29.98%
63,625 $13 Million
Q2 2018

Aug 08, 2018

SELL
$144.9 - $165.58 $761,739 - $870,454
-5,257 Reduced 5.47%
90,871 $13.4 Million
Q1 2018

May 11, 2018

SELL
$131.46 - $151.04 $3.46 Million - $3.97 Million
-26,296 Reduced 21.48%
96,128 $14.5 Million
Q4 2017

Feb 06, 2018

BUY
$121.17 - $134.75 $424,579 - $472,164
3,504 Added 2.95%
122,424 $15.8 Million
Q3 2017

Nov 07, 2017

BUY
$113.59 - $123.78 $13.5 Million - $14.7 Million
118,920
118,920 $14.4 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.